Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
438 participants
INTERVENTIONAL
2011-04-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Two Daily Disposable Contact Lenses.
NCT01300065
Safety and Efficacy of a Contact Lens for Daily Disposable Use
NCT01365039
One-Day Dispensing Clinical Evaluation of SofLens Daily Disposable Lenses Compared to a Marketed 1 Day Contact Lens
NCT00902850
A Study to Evaluate the Product Performance of a Daily Disposable Contact Lens
NCT01192126
A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses
NCT01309867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SofLens in investigational solution
Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.
SofLens in investigational solution
SofLens in investigational solution, worn on a daily disposable basis for 7 days.
SofLens in currently marketed solution
SofLens daily disposable contact lens packaged in currently marketed storage solution.
SofLens in currently marketed solution
SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SofLens in investigational solution
SofLens in investigational solution, worn on a daily disposable basis for 7 days.
SofLens in currently marketed solution
SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
* Subjects must be myopic and require contact lens correction from -0.50 D to -6.00 D in each eye.
* Subjects must be habitual wearers of daily disposable or planned replacement (at least every 3 months) soft contact lenses.
* Subjects must live/work in an urban environment at least 6 hours per day and for at least 4 days per week throughout the duration of the study.
* Subjects must be willing and able to wear the study lenses on a daily wear basis while in an urban environment.
* Subjects living/working in the urban environment must feel challenged by harsh, drying outdoor conditions (ie dust, pollution, smog).
* Subjects must feel that being in an urban environment has a negative effect on their lens wearing experience.
* Subjects must have access to an internet connection and be able to send and receive email.
Exclusion Criteria
* Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
* Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Subjects with an active ocular disease or who are using any ocular medication.
* Subjects with any grade 2 or greater finding during the slit lamp examination
* Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
* Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
* Subjects who are allergic to any component in the study care products.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch & Lomb, Inc.
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
691
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.